Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
NCCN and Flatiron Health are extending their decade-long collaboration through 2028, giving top cancer centers expanded access to real-world oncology data and a new AI-powered research platform. The renewed deal brings Flatiron Telescope to NCCN Member Institutions, making it easier for researchers to explore massive datasets without deep technical know-how. Biannual research grants and educational programming round out the package.
NCCN and Flatiron Health have renewed their collaboration—originally launched in 2014—through 2028, doubling down on their shared mission to advance real-world evidence (RWE) research across leading academic cancer centers. The renewed agreement keeps core offerings in place, including access to de-identified oncology datasets, analytic support, and educational programming, while adding a notable new tool: Flatiron Telescope, an AI-powered oncology intelligence platform designed to make research more accessible to a broader range of users.
Flatiron Telescope lets investigators dynamically explore large-scale datasets by biomarkers, lines of therapy, and treatment history—generating research cohorts on demand without requiring deep technical expertise. The goal is to accelerate study planning and help cancer centers tackle high-impact questions around patterns of care, predictive biomarkers, healthcare disparities, and comparative effectiveness.
By the Numbers
Why it matters: Real-world data is increasingly shaping how oncology guidelines are developed and how care gaps are identified. By expanding access to AI-driven research tools across NCCN's network of elite cancer centers, this partnership could meaningfully accelerate evidence generation—and ultimately improve cancer care delivery at scale.
